Quick Takeaways
- Richard A. Fair has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Richard A. Fair
- Location
- Houston, TX
- Signature
- /s/ Ben Hohl, by power of attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Richard A. Fair and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: BELLICUM PHARMACEUTICALS, INC ().
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Richard A. Fair
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BLCM | BELLICUM PHARMACEUTICALS, INC | President and CEO, Director | 15 Aug 2022 | |||
| CLVS | Clovis Oncology, Inc. | Director | 10 Jun 2021 | |||
| ELVN | Enliven Therapeutics, Inc. | PRESIDENT AND CEO, Director | 11 Dec 2025 |
Insider Transactions Reported by Richard A. Fair:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.